Ensho Therapeutics, Inc. funding
Ensho Therapeutics, Inc., a biotechnology company based in Woodcliff Lake, NJ (founded 2024), filed a Form D with the SEC on October 15, 2026 and reported $7.3M raised of a $15.6M offering.
Amount raised$7.3M
Offering size$15.6M
Filed with the SECOctober 15, 2026
First saleOctober 2, 2026
IndustryBiotechnology
SecuritiesEquity, Security to be acquired on exercise
LocationWoodcliff Lake, NJ
Founded2024
Entity typeCorporation
Investors so far7
Minimum investment$1
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Oct 15